Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?

by McCartney, Amelia, Di Leo, Angelo, Malorni, Luca
Published in Oncotarget (2018)

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

by Oakman, Catherine, Pestrin, Marta, Zafarana, Elena, Cantisani, Egidia, Di Leo, Angelo
Published 2010

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

by Curigliano, Giuseppe, Criscitiello, Carmen, Andrè, Fabrice, Colleoni, Marco, Di Leo, Angelo
Published 2013

Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer

by Oakman, Catherine, Pestrin, Marta, Bessi, Silvia, Galardi, Francesca, Di Leo, Angelo
Published 2010

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

by Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Published in BMC Med (2015)

Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer

by Oakman, Catherine, Bessi, Silvia, Zafarana, Elena, Galardi, Francesca, Biganzoli, Laura, Di Leo, Angelo
Published 2009

A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer

by Turner, Natalie, Forcato, Mattia, Nuzzo, Simona, Malorni, Luca, Bicciato, Silvio, Di Leo, Angelo
Published in NPJ Breast Cancer (2015)

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

by De Santo, Irene, McCartney, Amelia, Migliaccio, Ilenia, Di Leo, Angelo, Malorni, Luca
Published in Cancers (Basel) (2019)

Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?

by Turner, Natalie, Pestrin, Marta, Galardi, Francesca, De Luca, Francesca, Malorni, Luca, Di Leo, Angelo
Published 2014

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

by Rossi, Lorenzo, McCartney, Amelia, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Published in Ther Adv Med Oncol (2018)

Chromogenic in Situ Hybridization : A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples

by Tanner, Minna, Gancberg, David, Di Leo, Angelo, Larsimont, Denis, Rouas, Ghizlane, Piccart, Martine J., Isola, Jorma
Published 2000

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

by Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
Published in EPMA J (2015)

Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response

by Guarducci, Cristina, Bonechi, Martina, Boccalini, Giulia, Benelli, Matteo, Risi, Emanuela, Di Leo, Angelo, Malorni, Luca, Migliaccio, Ilenia
Published in Breast Care (Basel) (2017)

Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomize...

by Finn, Richard S., Press, Michael F., Dering, Judy, Arbushites, Michael, Koehler, Maria, Oliva, Cristina, Williams, Lisa S., Di Leo, Angelo
Published 2009

The role of abemaciclib in treatment of advanced breast cancer

by McCartney, Amelia, Moretti, Erica, Sanna, Giuseppina, Pestrin, Marta, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Published in Ther Adv Med Oncol (2018)

Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

by Pestrin, Marta, Salvianti, Francesca, Galardi, Francesca, De Luca, Francesca, Turner, Natalie, Malorni, Luca, Pazzagli, Mario, Di Leo, Angelo, Pinzani, Pamela
Published in Mol Oncol (2014)

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

by McCartney, Amelia, Vignoli, Alessia, Tenori, Leonardo, Fornier, Monica, Rossi, Lorenzo, Risi, Emanuela, Luchinat, Claudio, Biganzoli, Laura, Di Leo, Angelo
Published in NPJ Breast Cancer (2019)

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

by Robertson, John F. R., Jiang, Zefei, Di Leo, Angelo, Ohno, Shinji, Pritchard, Kathleen I., Ellis, Matthew, Bradbury, Ian, Campbell, Christine
Published in Breast Cancer (2019)

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer

by Migliaccio, Ilenia, Leo, Angela, Galardi, Francesca, Guarducci, Cristina, Fusco, Giulio Maria, Benelli, Matteo, Di Leo, Angelo, Biganzoli, Laura, Malorni, Luca
Published in Cancers (Basel) (2021)

Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing

by Salvianti, Francesca, Rotunno, Giada, Galardi, Francesca, De Luca, Francesca, Pestrin, Marta, Vannucchi, Alessandro Maria, Di Leo, Angelo, Pazzagli, Mario, Pinzani, Pamela
Published in Biomol Detect Quantif (2015)